Dr. Razi Khan is a cardiologist at Royal Columbian Hospital. His specialty interests include percutaneous coronary intervention for coronary artery disease, patent foramen ovale (PFO) closure/atrial septal defect (ASD) closure, balloon aortic valvuloplasty, novel therapies for mitral regurgitation and endoymocardial biopsies.
Areas of expertise
- Coronary artery disease
- Patent foramen ovale
- Atrial septal defects
- Valvular heart disease
- Heart failure
- Cardiac arrhythmias
- MD – 2006 – McGill University
- MSc – Epidemiology – 2014 – Harvard University (School of Public Health)
- Interventional Cardiology Fellowship – 2012-2014 – Montreal Heart Institute
- Internal Medicine/Cardiology – 2006-2012 – University of Western Ontario
- Khan R, Al-Hawwas M, Hatem R, Azzalini L, Fortier A, Joliecoeur EM, Tanguay JF, Lavoie-L'Allier P, Ly HQ. Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2016; 88:740-747.
- Khan R, Lopes R, Neely M, Alexander JH, Goodman SG. Characterizing and Predicting Bleeding Events Following an Acute Coronary Syndrome: Insights from the Apixiban for Prevention of Acute Ischemic Events (APPRAISE)-2 Trial. Heart. 2015;101:1475-84.
- Khan R, Spagnoli V, Tardif JC, L'Allier PL Novel anti-inflammatory therapies for the treatment of atherosclerosis. Atherosclerosis. Jun 2015: 497-509.
Research interests include outcome based studies and clinical trials in post-ACS patients.
- Examining outcomes amongst NSTEMI patients receiving medical management (VIGOUR Registry)
- Understanding the role of IL-B1 in atherosclerosis
Awards, honours, recognition and certification
- FRCP(C) – 2013 – Cardiology
- FRCP(C) – 2010 – Internal Medicine
- Echocardiography – 2012 – Level II
Monday to Friday, 9:00 a.m. to 4:30 p.m.